توجه: محتویات این صفحه به صورت خودکار پردازش شده و مقاله‌های نویسندگانی با تشابه اسمی، همگی در بخش یکسان نمایش داده می‌شوند.
۱Synthesis and cytotoxic activity of some 2–amino–4–aryl–3–cyano–7–(dimethylamino)–4H–chromenes
اطلاعات انتشار: Research in Pharmaceutical Sciences، پنجم،شماره۱(پياپي ۹)، ۲۰۱۰، سال
تعداد صفحات: ۶
A series of 2–amino–4–aryl–3–cyano–7–(dimethylamino)–4H–chromenes was synthesized by condensation of 3–(dimethylamino)phenol, an aromatic aldehyde and malonitrile in ethanol containing piperidine. The assignments of the structure of all synthesized compounds were based on spectral data (IR, Mass and 1H NMR). The cytotoxic activities of the synthesized compounds against six human tumor cell lines were determined by MTT assay. Several compounds showed significant cytotoxic activity.

۲A structural model of the anaphase promoting complex co–activator (Cdh1) and in silico design of inhibitory compounds
اطلاعات انتشار: Research in Pharmaceutical Sciences، دهم،شماره۱(پياپي ۲۸)، ۲۰۱۵، سال
تعداد صفحات: ۹
Anaphase promoting complex (APC) controls cell cycle and chromosome segregation. The APC activation occurs after binding of co–activators, cdh1 and cdc20. Cdh1 plays a role in cancer pathogenesis and is known as a potential drug target. The main aim of this study was prediction of 3D structure of cdh1 and designing the inhibitory compounds based on the structural model. First, 3D structure of cdh1 was predicted by means of homology modelling and molecular dynamics tools, MODELLER and Gromacs package, respectively. Then, inhibitory compounds were designed using virtual screening and molecular docking by means AutoDock package. The overall structure of cdh1 is propeller like and each DW40 repeat contains four anti–parallel beta–sheets. Moreover, binding pocket of the inhibitory compounds was determined. The results might be helpful in finding a suitable cdh1 inhibitor for the treatment of cancer.
نمایش نتایج ۱ تا ۲ از میان ۲ نتیجه